These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 16723215)

  • 1. The ICH S8 immunotoxicity guidance. Immune function assessment and toxicological pathology: autonomous or synergistic methods to predict immunotoxicity?
    Spanhaak S
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):373-6. PubMed ID: 16723215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory aspects of immunotoxicology.
    Schulte A; Ruehl-Fehlert C
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):385-9. PubMed ID: 16713214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Conference on Harmonisation; Guidance on S8 Immunotoxicity Studies for Human Pharmaceuticals; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Apr; 71(71):19193-4. PubMed ID: 16612859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status and burning issues in immunotoxicity testing of drugs.
    van der Laan JW; van Loveren H
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):435-40. PubMed ID: 15982690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune function tests for hazard identification: a paradigm shift in drug development.
    Gore ER
    Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):331-5. PubMed ID: 16623854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for developmental immunotoxicity guidance and an update on ICH S8.
    Hastings KL
    J Immunotoxicol; 2005 Oct; 2(4):217-20. PubMed ID: 18958677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of histopathology in the identification of immunotoxicity.
    Haley PJ
    J Immunotoxicol; 2005 Oct; 2(4):181-3. PubMed ID: 18958671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the ICH guidelines for immunotoxicology evaluation of pharmaceuticals using a survey of industry practices.
    Weaver JL; Tsutsui N; Hisada S; Vidal JM; Spanhaak S; Sawada J; Hastings KL; van der Laan JW; van Loveren H; Kawabata TT; Sims J; Durham SK; Fueki O; Matula TI; Kusunoki H; Ulrich P; Nakamura K
    J Immunotoxicol; 2005 Jul; 2(3):171-80. PubMed ID: 18958670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory immunotoxicology: does the published evidence support mandatory nonclinical immune function screening in drug development?
    Snodin DJ
    Regul Toxicol Pharmacol; 2004 Dec; 40(3):336-55. PubMed ID: 15546688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of immunotoxicity testing strategies for immunomodulatory drugs.
    Kawabata TT; Evans EW
    Toxicol Pathol; 2012; 40(2):288-93. PubMed ID: 22228792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harmonization of immunotoxicity guidelines in the ICH process--pathology considerations from the guideline Committee of the European Society of Toxicological Pathology (ESTP) .
    Ruehl-Fehlert C; Bradley A; George C; Germann PG; Bolliger AP; Schultee A;
    Exp Toxicol Pathol; 2005 Aug; 57(1):1-5. PubMed ID: 16089314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immune system--multiple sites but one system.
    Harleman JH
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):359-61. PubMed ID: 16730433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of immunotoxicity in safety assessment: a medical toxicologist's perspective.
    Descotes J
    Toxicol Lett; 2004 Apr; 149(1-3):103-8. PubMed ID: 15093254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodologies for developmental immunotoxicity (DIT) testing.
    Dietert RR; Holsapple MP
    Methods; 2007 Jan; 41(1):123-31. PubMed ID: 17161309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: a workshop summary.
    Boverhof DR; Ladics G; Luebke B; Botham J; Corsini E; Evans E; Germolec D; Holsapple M; Loveless SE; Lu H; van der Laan JW; White KL; Yang Y
    Regul Toxicol Pharmacol; 2014 Feb; 68(1):96-107. PubMed ID: 24280359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General aspects of immunotoxicology including validation issues.
    Frieke Kuper C
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):363-6. PubMed ID: 16709446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of xenobiotics for direct immunotoxicity in an animal study.
    De Jong WH; Van Loveren H
    Methods; 2007 Jan; 41(1):3-8. PubMed ID: 17161297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro testing for direct immunotoxicity: state of the art.
    Lankveld DP; Van Loveren H; Baken KA; Vandebriel RJ
    Methods Mol Biol; 2010; 598():401-23. PubMed ID: 19967527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproductive toxicity testing for pharmaceuticals under ICH.
    Barrow PC
    Reprod Toxicol; 2009 Sep; 28(2):172-9. PubMed ID: 19631153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.